Medical device firm Retractable's Q3 sales dip

Retractable Technologies' Q3 2025 sales slightly declined to $10.1 million from $10.3 million last year. Operating loss reduced to $3.7 million from $5.1 million. The company reported a net income of $371 thousand, aided by $2.4 million unrealized gains. Tariffs continue to impact costs, with $2.3 million spent on tariffs in the first nine months of 2025. International revenues increased by 25% in Q3, but average selling price declined due to product discounts.